BlackRock’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

BlackRock’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,028	Closed	-$85K	–	3233
2014 Q4	$85K	Buy	5,028 +1,029	+26%	+$14.5K	﹤0.01%	1780
2014 Q3	$48K	Hold	3,999	–	–	﹤0.01%	1929
2014 Q2	$23K	Buy	3,999 +72	+2%	+$332	﹤0.01%	2312
2014 Q1	$14K	Hold	3,927	–	–	﹤0.01%	2559
2013 Q4	$13K	Hold	3,927	–	–	﹤0.01%	2593
2013 Q3	$17K	Hold	3,927	–	–	﹤0.01%	2369
2013 Q2	$18K	Buy	+3,927	New	+$13.5K	﹤0.01%	2373

BlackRock's AVNR Position: Q1 2015 in Review

BlackRock sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 5,028 shares — an estimated $85K sold.

BlackRock first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $85K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

BlackRock reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
BlackRock sold 5,028 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $85K.
BlackRock first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
BlackRock's AVANIR PHARMACEUTICALS, INC CL A position peaked at $85K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on BlackRock's 13F filing for Q1 2015, filed 13 May 2015.